|
1
|
Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer.
|
J Clin Oncol
|
2011
|
3.12
|
|
2
|
Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?
|
J Thorac Oncol
|
2009
|
1.82
|
|
3
|
The impact of consenter characteristics and experience on patient interest in clinical research.
|
Oncologist
|
2009
|
1.57
|
|
4
|
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
|
Mult Scler
|
2013
|
1.47
|
|
5
|
Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation.
|
Cancer Res
|
2010
|
1.20
|
|
6
|
Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse population.
|
J Thorac Oncol
|
2010
|
1.10
|
|
7
|
Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma.
|
Clin Cancer Res
|
2013
|
1.07
|
|
8
|
Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy.
|
Clin Cancer Res
|
2011
|
1.06
|
|
9
|
Impact of routine cavity shave margins on breast cancer re-excision rates.
|
Ann Surg Oncol
|
2010
|
1.03
|
|
10
|
A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma.
|
Lung Cancer
|
2012
|
1.03
|
|
11
|
Demographic and urodynamic factors associated with persistent OAB after anterior compartment prolapse repair.
|
Neurourol Urodyn
|
2010
|
1.01
|
|
12
|
Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.
|
Clin Lung Cancer
|
2013
|
0.96
|
|
13
|
Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
|
Clin Lung Cancer
|
2012
|
0.91
|
|
14
|
Consent timing and experience: modifiable factors that may influence interest in clinical research.
|
J Oncol Pract
|
2011
|
0.89
|
|
15
|
Influence of surgical technique on mastectomy and reexcision rates in breast-conserving therapy for cancer.
|
Int J Surg Oncol
|
2012
|
0.86
|
|
16
|
How have we diagnosed early-stage lung cancer without radiographic screening? A contemporary single-center experience.
|
PLoS One
|
2012
|
0.85
|
|
17
|
Predictors and impact of second-line chemotherapy for advanced non-small cell lung cancer in the United States: real-world considerations for maintenance therapy.
|
J Thorac Oncol
|
2011
|
0.85
|
|
18
|
Endoscopic hemostasis in nonvariceal upper gastrointestinal bleeding: comparison of physician practice in the East and the West.
|
Dig Dis Sci
|
2009
|
0.79
|
|
19
|
Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index.
|
Int J Clin Oncol
|
2014
|
0.78
|
|
20
|
ERCC1 expression and outcomes in head and neck cancer treated with concurrent cisplatin and radiation.
|
Anticancer Res
|
2011
|
0.78
|
|
21
|
The effect of providing power mobility on body weight change.
|
Am J Phys Med Rehabil
|
2007
|
0.75
|